Lijun Shen

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Xiao-Jing Zhang, Juan‐Juan Qin, Xu Cheng et al. · Cell Metabolism · 2020 · 492 citations · Full text

Reduced Risk, Preventive Medicine, Long Covid +12

An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury

Xiao‐Jing Zhang, Xu Cheng, Zhenzhen Yan et al. · Nature Medicine · 2017 · 222 citations

Key Mediator, Oxidative Stress, Inflammation +17

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

Pi‐Xiao Wang, Yan‐Xiao Ji, Xiao‐Jing Zhang et al. · Nature Medicine · 2017 · 215 citations

Inflammation, Autoimmune Disease, Hepatology +15

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Chongshu Jian, Jiajun Fu, Xu Cheng et al. · Cell Metabolism · 2020 · 164 citations · Full text

Hepatology, Low-dose Sorafenib Acts, Nonalcoholic Fatty Liver Disease +14

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4

Guang‐Nian Zhao, Peng Zhang, Jun Gong et al. · Nature Medicine · 2017 · 149 citations

Inflammation, Metabolic Syndrome, Autoimmune Disease +13